IRIDEX CORP — Director's Dealing 2015

Mar 18, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IRIDEX CORP (IRIX)
CIK: 0001006045
Period of Report: 2015-03-17

Reporting Person: Steckel Ronald (VP, Operations)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-17	Common Stock	M	1375	$3.856	Acquired	32089	Direct
2015-03-17	Common stock	S	1375	$10.079	Disposed	30714	Direct
2015-03-17	Common Stock	M	9983	$3.99	Acquired	40697	Direct
2015-03-17	Common Stock	S	9983	$10.079	Disposed	30714	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-03-17	Stock Option Right to Buy	$3.856	M	1375	Disposed	2017-01-01	Common Stock (1375)	Direct
2015-03-17	Stock Option Right to Buy	$3.99	M	9983	Disposed	2016-04-16	Common Stock (9983)	Direct

Footnotes

F1: The sale reported in this Form 4 was pursuant to the Reporting Person's Rule 10b5-1 Selling Plan effective 12/5/14.

F2: The sales price reported in Column 4 of Table 1 represents the weighted average sale price of the shares sold, ranging from $10.00 to $10.24 per share. Upon request by the Commission staff, the Issuer, or a security holder of Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.

F3: This option was granted pursuant to IRIDEX Corporation's 2008 Equity Incentive Plan and is exempt to Rule 16b-3.

F4: The shares are subject to vesting according to the following schedule: 1/48th of the total number of shares vest each month.

F5: The shares shall vest as follows: 12/48ths of the shares shall vest 12 months after the Vesting Commencement Date and 1/48th of the shares shall vest each month thereafter.